OMCL
OMNICELL, INC.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$32.23
−1.20%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $0.42
- Revenue estimate
- $304.4M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $0.94
- EPS estimate
- $0.47
- Revenue actual
- $312.2M
- Revenue estimate
- $310.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +48.6%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $53
- PT range
- $45 – $65
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $0.47 | $0.94 | Beat 101.07% | $312.2M |
| Apr 28, 2026 | $0.33 | $0.55 | Beat 66.67% | $309.9M |
| Feb 5, 2026 | $0.47 | $0.40 | Miss -14.89% | $314.0M |
| Oct 30, 2025 | $0.36 | $0.51 | Beat 41.67% | $310.6M |
| Jul 31, 2025 | $0.31 | $0.45 | Beat 45.16% | $290.6M |
| Feb 6, 2025 | $0.57 | $0.60 | Beat 5.26% | $306.9M |
| Aug 1, 2024 | $0.16 | $0.51 | Beat 218.75% | $276.8M |
| May 2, 2024 | -$0.08 | $0.03 | Beat 137.50% | $246.2M |
| Feb 8, 2024 | $0.17 | $0.33 | Beat 94.12% | $258.8M |
| Nov 2, 2023 | $0.45 | $0.62 | Beat 37.78% | $298.7M |
| May 2, 2023 | $0.07 | $0.39 | Beat 457.14% | $290.6M |
| Feb 28, 2023 | $0.09 | $0.33 | Beat 266.67% | $297.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026